Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Infectious Disease Clinics of North America|June 1, 1993
Problems with detection of beta-lactam resistance among nonfastidious gram-negative bacilliC C Sanders, K S Thomson, P A BradfordCalcified Tissue International|August 24, 1979
X-ray diffraction of the calcified tissues in PolypterusD K Meinke, H C Skinner, K S ThomsonThe Journal of Antimicrobial Chemotherapy|May 1, 1994
USA resistance patterns among UTI pathogensK S Thomson, W E Sanders, C C SandersDrugs Under Experimental and Clinical Research|January 11, 1991
In vitro studies with Bay V 3522, a new oral cephalosporinK S Thomson, C C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|November 1, 1991
In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance risesK S Thomson, C C Sanders, M E HaydenPlanta|January 30, 2014
1-N-naphthylphthalamic acid and 2,3,5-triiodobenzoic acid : In-vitro binding to particulate cell fractions and action on auxin transport in corn coleoptilesK S Thomson, R Hertel, S Müller, et al.Science (New York, N.Y.)|August 25, 1978
Cyclic change in late triassic lacustrine communitiesP E Olsen, C L Remington, B Cornet, et al.Diagnostic Microbiology and Infectious Disease|May 5, 2001
Activity of oral agents against pediatric isolates of Streptococcus pneumoniaeJ Black, E S Moland, S A Chartrand, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1989
Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamasesC C Sanders, W E Sanders, K S Thomson, et al.The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistanceK S Thomson, S A Chartrand, C C Sanders, et al.Pageof 6